These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35806104)

  • 1. Molecular Research on Muscle Protein and Myopathies.
    Karpicheva O
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweetening the pot in muscle: genetic defects of protein glycosylation causing muscle disease.
    Karpati G; Holland P
    Neurology; 2002 Dec; 59(11):1674-6. PubMed ID: 12473751
    [No Abstract]   [Full Text] [Related]  

  • 3. 121st ENMC International Workshop on Desmin and Protein Aggregate Myopathies. 7-9 November 2003, Naarden, The Netherlands.
    Goebel H; Fardeau M
    Neuromuscul Disord; 2004 Nov; 14(11):767-73. PubMed ID: 15482963
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal distribution of calcium-handling proteins: a novel distinctive marker in core myopathies.
    Herasse M; Parain K; Marty I; Monnier N; Kaindl AM; Leroy JP; Richard P; Lunardi J; Romero NB; Ferreiro A
    J Neuropathol Exp Neurol; 2007 Jan; 66(1):57-65. PubMed ID: 17204937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein aggregate myopathies.
    Goebel HH; Müller HD
    Semin Pediatr Neurol; 2006 Jun; 13(2):96-103. PubMed ID: 17027859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Childhood reducing body myopathy caused by FHL1 gene variation in a child].
    Wei CJ; Wang ZX; Chang XZ; Lyu JL; Ge L; Fan YB; Zhang YH; Xiong H
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):147-149. PubMed ID: 32102154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin overexpression in skeletal muscle produces a progressive myopathy.
    Glover LE; Newton K; Krishnan G; Bronson R; Boyle A; Krivickas LS; Brown RH
    Ann Neurol; 2010 Mar; 67(3):384-93. PubMed ID: 20373350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states.
    Argilés JM; López-Soriano FJ
    Trends Pharmacol Sci; 1996 Jun; 17(6):223-6. PubMed ID: 8763200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular aggregates in skeletal muscle: just a special type of protein aggregates?
    Schiaffino S
    Neuromuscul Disord; 2012 Mar; 22(3):199-207. PubMed ID: 22154366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital myopathies: diseases of the actin cytoskeleton.
    Clarkson E; Costa CF; Machesky LM
    J Pathol; 2004 Nov; 204(4):407-17. PubMed ID: 15495263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversification of the muscle proteome through alternative splicing.
    Nakka K; Ghigna C; Gabellini D; Dilworth FJ
    Skelet Muscle; 2018 Mar; 8(1):8. PubMed ID: 29510724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease.
    Bohnert KR; McMillan JD; Kumar A
    J Cell Physiol; 2018 Jan; 233(1):67-78. PubMed ID: 28177127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands.
    Jungbluth H; Beggs A; Bönnemann C; Bushby K; Ceuterick-de Groote C; Estournet-Mathiaud B; Goemans N; Guicheney P; Lescure A; Lunardi J; Muntoni F; Quinlivan R; Sewry C; Straub V; Treves S; Ferreiro A
    Neuromuscul Disord; 2004 Nov; 14(11):754-66. PubMed ID: 15482962
    [No Abstract]   [Full Text] [Related]  

  • 14. Myopathies resulting from mutations in sarcomeric proteins.
    Bönnemann CG; Laing NG
    Curr Opin Neurol; 2004 Oct; 17(5):529-37. PubMed ID: 15367857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane traffic and muscle: lessons from human disease.
    Dowling JJ; Gibbs EM; Feldman EL
    Traffic; 2008 Jul; 9(7):1035-43. PubMed ID: 18266915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular dystrophy and other myopathies. Troponin activity of natural actomyosin from skeletal muscle.
    Furukawa T; Peter JB
    Arch Neurol; 1972 May; 26(5):385-90. PubMed ID: 5026268
    [No Abstract]   [Full Text] [Related]  

  • 17. A Dominant C150Y Mutation in FHL1 Induces Structural Alterations in LIM2 Domain Causing Protein Aggregation In Human and Drosophila Indirect Flight Muscles.
    Santhoshkumar R; Preethish-Kumar V; Mangalaparthi KK; Unni S; Padmanabhan B; T S KP; Nongthomba U; Atchayaram N; Narayanappa G
    J Mol Neurosci; 2021 Nov; 71(11):2324-2335. PubMed ID: 33515430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.
    Dowling JJ; Arbogast S; Hur J; Nelson DD; McEvoy A; Waugh T; Marty I; Lunardi J; Brooks SV; Kuwada JY; Ferreiro A
    Brain; 2012 Apr; 135(Pt 4):1115-27. PubMed ID: 22418739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational control of muscle mass.
    Dupont-Versteegden EE; McCarthy JJ
    J Appl Physiol (1985); 2019 Aug; 127(2):579-580. PubMed ID: 31446832
    [No Abstract]   [Full Text] [Related]  

  • 20. Adiponectin in Myopathies.
    Gamberi T; Magherini F; Fiaschi T
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.